influenza
acut
respiratori
ill
manifest
form
typic
season
epidem
winter
character
pandem
antigen
distinct
viru
introduc
spread
human
popul
industri
countri
influenza
constitut
signific
risk
public
health
caus
signific
damag
nation
health
servic
societi
health
econom
term
inde
respons
high
consumpt
healthcar
resourc
direct
cost
reduc
product
indirect
cost
intang
cost
suffer
impair
qualiti
life
also
prove
number
influenza
respons
increas
recours
gener
medic
care
increas
hospitalis
excess
basi
us
popul
molinari
et
al
estim
annual
influenza
epidem
result
averag
direct
medic
cost
billion
averag
indirect
cost
estim
cost
season
epidem
itali
rang
billion
per
year
cost
pandem
rang
subject
elderli
young
children
pregnant
women
peopl
certain
health
condit
high
risk
seriou
influenza
complic
excess
mortal
due
influenza
excess
hospit
occur
among
moreov
underlin
us
center
diseas
control
cdc
complic
influenza
often
affect
person
age
especi
age
well
children
peopl
age
recogn
risk
acknowledg
realli
effect
mean
combat
influenza
possibl
complic
mani
studi
support
hypothesi
influenza
vaccin
significantli
reduc
risk
sever
complic
eg
hospit
pneumonia
death
among
elderli
live
subject
age
vaccin
influenza
seem
reduc
hospit
mortal
howev
studi
open
potenti
bia
sinc
sever
variabl
influenc
evalu
efficacyeffect
need
ever
immunogen
efficaci
influenza
vaccin
especi
elderli
prompt
develop
adjuv
vaccin
order
enhanc
immun
respons
influenza
vaccin
sever
adjuv
propos
eg
virosom
adjuv
agent
incorpor
vaccin
enhanc
immunogen
antigen
activ
andor
prolong
stimulatori
effect
itali
influenza
vaccin
strongli
recommend
elderli
offer
free
charg
vaccin
facil
local
healthcar
unit
lhu
gener
practition
gp
reason
import
evalu
perform
season
influenza
vaccin
campaign
perspect
studi
prevent
hospit
appear
use
hospit
elderli
largest
item
direct
cost
least
season
influenza
epidem
tradit
vaccin
adjuv
adjuv
vaccin
studi
regard
effect
reduc
hospit
mortal
elderli
studi
conduct
inflex
studi
effect
inflex
perform
term
prevent
influenzalik
ill
ili
order
evalu
effect
adjuv
season
influenza
vaccin
avail
itali
prevent
hospit
influenza
pneumonia
match
casecontrol
studi
perform
elderli
subject
season
genoa
itali
liguria
region
influenza
activ
moder
season
influenza
epidem
began
week
last
week
epidem
period
last
week
time
estim
region
popul
suffer
influenza
infant
children
adolesc
subject
affect
influenza
case
fell
ageclass
predomin
circul
influenza
viru
follow
b
viru
season
optim
match
circul
virus
vaccin
strain
drift
influenza
strain
isol
genoa
district
influenza
vaccin
coverag
elderli
genoa
basi
distribut
vaccin
use
elderli
subject
vaccin
inflex
respect
data
liguria
regioninfluenza
vaccin
season
total
case
male
femal
control
recruit
seven
case
exclud
match
suitabl
control
tabl
show
person
clinic
characterist
case
control
smoke
drink
significantli
common
among
case
control
furthermor
case
control
suffer
heart
diseas
p
respiratori
diseas
p
renal
diseas
p
contrast
control
often
affect
rheumatolog
diseas
p
highrisk
medic
condit
hypertens
liver
diseas
cancer
similarli
distribut
among
case
control
pneumococc
vaccin
receiv
case
control
pneumococc
vaccin
statu
could
ascertain
case
control
number
subject
three
risk
factor
significantli
higher
among
case
p
tabl
influenza
vaccin
statu
case
control
report
figur
total
case
vaccin
receiv
inflex
respect
vaccin
case
highrisk
medic
condit
specif
highrisk
medic
condit
condit
condit
condit
condit
condit
fourteen
vaccin
case
smoker
drinker
among
control
vaccin
receiv
inflex
respect
highrisk
medic
condit
record
among
vaccin
control
follow
subject
highrisk
condit
condit
condit
condit
condit
thirteen
vaccin
control
smoker
drinker
tabl
reveal
mani
elderli
subject
underli
chronic
medic
condit
vaccin
therefor
expos
high
risk
develop
seriou
complic
caus
influenza
exampl
heart
respiratori
diseas
respect
vaccin
accord
aim
studi
risk
hospit
pneumonia
andor
influenza
effect
influenza
vaccin
prevent
hospit
influenza
pneumonia
assess
subject
receiv
adjuv
influenza
vaccin
receiv
vaccin
exclud
follow
statist
test
casecontrol
pair
analyz
casecontrol
pair
consid
overal
effect
adjuv
influenza
vaccin
multivari
logist
model
includ
addit
elderli
statu
follow
confound
factor
chang
crudeor
drink
smoke
crude
influenza
vaccin
effect
adjust
valu
tabl
consid
effect
inflex
vaccin
multivari
logist
model
includ
addit
elderli
statu
follow
confound
factor
chang
crudeor
heart
respiratori
diseas
drink
smoke
crude
inflex
vaccin
effect
adjust
valu
tabl
regard
vaccin
multivari
logist
model
includ
addit
elderli
statu
follow
confound
factor
chang
crudeor
respiratori
diseas
drink
smoke
crude
vaccin
effect
adjust
valu
tabl
howev
regard
adjust
analysi
prove
statist
signific
p
furthermor
ci
adjust
also
confirm
adjust
consid
indic
valu
cours
life
human
infect
sever
strain
influenza
viru
elderli
therefor
rich
immunolog
memori
influenza
virus
howev
immun
system
weaken
data
obtain
inactiv
nonadjuv
influenza
vaccin
use
differ
season
indic
earli
age
intens
respons
vaccin
subsequ
time
pass
age
progress
underli
diseas
especi
respiratori
cardiovascular
system
make
elderli
vulner
aggress
influenza
virus
respiratori
pathogen
basi
result
possibl
estim
elderli
adjuv
influenza
vaccin
consid
togeth
inflex
associ
signific
reduct
risk
hospit
influenza
pneumonia
inde
effect
prevent
hospit
ci
moreov
studi
first
provid
inform
effect
inflex
vaccin
term
reduc
hospit
influenza
pneumonia
among
subject
demonstr
vaccin
yield
high
degre
protect
inform
consist
result
obtain
pregliasco
et
al
consonni
et
although
author
consid
anoth
outcom
ie
efficaci
virosom
influenza
vaccin
prevent
influenzalik
ill
elderli
particular
consonni
et
al
perform
studi
influenza
season
found
rate
protect
analysi
show
much
greater
effect
reduc
hospit
influenza
pneumonia
studi
inde
practic
previou
research
regist
similar
level
effect
one
studi
conduct
found
vaccin
efficaci
regard
radiolog
confirm
pneumonia
casecontrol
studi
perform
herrera
show
vaccin
efficaci
influenza
hospit
though
nonhighrisk
import
underlin
major
studi
influenza
vaccin
efficacyeffect
two
studi
predictor
vaccin
consid
independ
type
vaccin
administ
howev
probabl
vaccin
use
inactiv
nonadjuv
vaccin
casecontrol
studi
conduct
sinc
shown
vaccin
efficacyeffect
regard
two
recent
studi
produc
result
quit
similar
one
publish
talbot
et
al
author
consid
effect
season
vaccin
prevent
hospit
elderli
patient
appli
molecular
biolog
techniqu
confirm
influenza
result
studi
show
effect
ci
combin
consecut
season
studi
publish
castilla
et
al
show
effect
ci
prevent
hospit
import
note
howev
subject
latter
studi
vaccin
inactiv
nonadjuv
vaccin
howev
mention
difficult
evalu
influenza
vaccin
effect
exactli
sinc
influenc
sever
variabl
one
main
factor
concord
strain
use
immun
virus
circul
among
popul
match
variabl
characterist
pathogen
circul
strain
outcom
case
definit
method
use
medic
condit
vaccin
recipi
period
studi
contemporari
circul
differ
respiratori
pathogen
often
occur
lack
inform
type
vaccin
administ
despit
difficulti
author
tri
limit
variabl
find
differ
studi
use
metaanalysi
methodolog
instanc
gross
et
al
perform
metaanalysi
studi
found
rate
efficaci
prevent
vu
et
al
perform
metaanalysi
studi
involv
noninstitution
subject
age
found
rate
effect
prevent
hospit
pneumonia
jefferson
et
al
publish
paper
report
wellmatch
vaccin
prevent
ci
hospit
admiss
caus
although
metaanalysi
studi
interest
sever
major
limit
import
one
studi
usual
conduct
independ
repeat
yearli
vaccin
type
dosag
time
administr
schedul
variou
influenza
vaccin
furthermor
author
complet
ignor
technolog
evolut
influenza
vaccin
studi
period
techniqu
determin
antigen
dose
introduct
nation
intern
qualiti
control
etc
addit
studi
differ
power
differ
specif
outcom
combin
consid
equal
result
difficult
interpret
often
order
limit
multipl
effect
great
number
variabl
influenc
effect
influenza
vaccin
studi
design
take
account
possibl
select
inform
bia
confound
bia
studi
perform
period
maximum
incid
ili
decemb
furthermor
period
respiratori
virus
respiratori
synciti
viru
rsv
adenoviru
parainfluenzaviru
rhinoviru
coronaviru
metapneumoviru
cocircul
influenza
virus
fig
cocircul
respiratori
virus
particular
import
infant
could
import
term
inform
bia
howev
well
known
kind
bia
lead
underestim
select
case
two
largest
hospit
genoa
gp
subject
identifi
start
gp
databas
appropri
control
subject
match
case
age
sex
socioeconom
level
type
vaccin
procedur
enabl
us
minimis
variabl
within
casecontrol
pair
yield
case
control
resid
neighborhood
citi
inform
hospit
discharg
diagnos
underli
diseas
life
style
risk
condit
obtain
medic
record
regard
case
also
hospit
medic
record
two
oper
codifi
data
collect
mean
ad
hoc
questionnair
author
paper
supervis
phase
studi
ensur
qualiti
data
fed
comput
statist
analysi
multivari
analysi
conduct
order
limit
confound
bias
link
comorbid
risk
factor
particular
final
analysi
perform
consid
predictor
chang
crude
studi
effect
prevent
hospit
influenza
pneumonia
prove
higher
report
author
reason
could
good
match
vaccin
circul
influenza
strain
fact
elderli
vaccin
unvaccin
probabl
previou
contact
strain
close
relat
viru
demonstr
low
morbid
subject
pandem
confirm
studi
hancock
et
al
report
high
percentag
neutral
antibodi
titer
pandem
viru
among
serum
donor
born
thu
vaccin
might
potent
booster
action
inde
studi
support
hypothesi
stimul
action
adjuv
vaccin
studi
statist
analysi
perform
regard
type
vaccin
adjuv
vaccin
consid
studi
show
good
level
effect
inflex
respect
howev
result
display
statist
signific
inflex
p
statist
signific
reach
p
furthermor
ci
adjust
also
confirm
adjust
consid
indic
valu
regard
effect
subunit
influenza
vaccin
prevent
hospitalis
et
al
conduct
casecontrol
studi
influenza
season
effect
influenza
vaccin
prevent
hospitalis
cardiovascular
diseas
cerebrovascular
diseas
pneumonia
result
highlight
fact
mani
subject
two
concomit
highrisk
condit
vaccin
influenza
exampl
case
heart
diseas
respiratori
diseas
vaccin
although
italian
ministri
health
set
object
vaccin
elderli
popul
annual
influenza
vaccin
campaign
current
coverag
itali
whole
genoa
data
liguria
region
influenza
vaccin
season
reason
import
rais
awar
util
influenza
vaccin
elderli
also
advis
implement
train
cours
gp
furthermor
occas
annual
influenza
vaccin
campaign
use
vaccin
elderli
pneumococc
infect
inde
synerg
influenza
infect
greater
suscept
streptococcu
pneumonia
well
regard
item
result
also
demonstr
vaccin
pneumonia
significantli
frequent
among
control
case
although
pneumococc
vaccin
statu
mani
subject
case
control
could
ascertain
conclus
result
indic
adjuv
vaccin
seem
fulfil
purpos
design
particular
find
reveal
high
efficaci
inflex
even
basi
lower
limit
ci
adopt
conserv
estim
effect
hypothes
use
vaccin
influenza
prevent
would
yield
consider
save
nation
health
servic
howev
fact
influenza
diagnos
confirm
laboratori
suggest
result
consid
caution
studi
need
order
confirm
excel
perform
inflex
prevent
hospit
influenza
pneumonia
casecontrol
studi
perform
elderli
popul
age
resid
genoa
itali
account
elderli
subject
male
femal
decemb
case
control
match
ratio
match
base
gender
age
socioeconom
statu
evalu
basi
educ
level
district
resid
type
influenza
vaccin
case
match
control
gp
region
health
servic
rh
provid
vaccin
influenza
vaccin
campaign
particular
inflex
crucel
itali
srl
novarti
vaccin
diagnost
srl
sanofi
pasteur
msd
spa
use
elderli
case
recruit
among
hospit
subject
choos
patient
discharg
diagnos
influenza
pneumonia
hospit
discharg
code
two
import
hospit
genoa
consid
recruit
azienda
ospedaliera
universitaria
san
martino
ent
ospedaliero
ospedali
galliera
control
subject
hospit
influenza
pneumonia
studi
period
control
recruit
gp
soon
recruit
case
gp
pick
potenti
control
subject
fit
control
definit
among
patient
regist
databas
group
potenti
candid
gp
randomli
select
control
subject
influenza
season
consid
sinc
diagnosi
influenza
base
hospit
discharg
code
improv
specif
diagnosi
studi
took
account
period
maximum
incid
ili
decemb
march
fig
databas
interunivers
centr
research
influenza
transmit
infect
ciriit
monitor
trend
influenza
throughout
year
consid
epidemiolog
virolog
data
real
ciriit
locat
health
scienc
depart
univers
genoa
part
italian
influenza
surveil
system
written
consent
obtain
data
case
control
collect
mean
ad
hoc
written
questionnair
inform
obtain
valid
gp
medic
record
regard
case
also
hospit
medic
record
follow
variabl
record
age
gender
socioeconom
statu
chronic
condit
cardiovascular
diseas
cerebrovascular
event
regular
treatment
hypertens
agent
chronic
respiratori
diseas
diabet
mellitu
renal
diseas
hepat
diseas
rheumat
diseas
neoplasia
furthermor
subject
ask
smoke
drink
habit
whether
receiv
pneumococc
vaccin
influenza
pneumococc
vaccin
statu
check
use
vaccin
regist
gp
lhu
vaccin
subject
enrol
receiv
influenza
vaccin
season
campaign
vaccin
novemb
analys
perform
spss
window
graphpad
softwar
characterist
studi
popul
describ
mean
standard
deviat
sd
continu
variabl
proport
categor
one
differ
among
case
control
group
analyz
macnemar
test
vaccin
effect
calcul
ive
crude
odd
ratio
rel
confid
interv
ci
estim
condit
logist
regress
model
use
dichotom
variabl
hospit
influenza
pneumonia
outcom
vaccin
main
predictor
otherwis
adjust
or
estim
multivari
logist
model
evalu
role
possibl
confound
factor
variabl
measur
studi
heart
diseas
respiratori
diseas
alcohol
consumpt
smoke
etc
variabl
result
chang
effect
exposur
includ
model
owe
import
variabl
age
includ
multivari
analysi
estim
coeffici
logist
regress
obtain
use
procedur
spss
coxregr
equival
condit
logist
regress
one
case
one
control
everi
accord
goal
studi
effect
influenza
vaccin
prevent
hospit
influenza
pneumonia
assess
subject
receiv
adjuv
influenza
vaccin
consequ
analysi
perform
total
sampl
subject
vaccin
inflex
restrict
case
vaccin
inflex
respect
test
twosid
p
consid
statist
signific
